Literature DB >> 16522163

Derivation of three clones from human embryonic stem cell lines by FACS sorting and their characterization.

Kuldip S Sidhu1, Bernard E Tuch.   

Abstract

Here we describe the first report of three human embryonic stem cell (hESC) clones, hES 3.1, 3.2, and 3.3, derived from the parent line hES3 by sorting of single-cell preparations by flow cytometry. The viability of single-cell preparations before and after cell sorting remained >98%. The hESC were selected by size gating and forward-angle light scatter and were dispersed directly as single cell/ well into 96-well plates containing human fetal fibroblasts as feeder layers. Single stem cell dispersion into 96-well plates was confirmed by using cells from a hES3 line that constitutively expressed green fluorescence protein (eGFP) under similar conditions of flow cytometry. Three clones were obtained from the parent line hES3 -- hES3.1, 3.2, and 3.3 -- and they have been in continuous culture for more than 1 year. The cloning efficiency was less than <0.5%. These hESC clones show normal stem cell characteristics, such as undifferentiated growth, high nucleocytoplasmic ratio, the same karyotype as that of the parent line (46 XX), stem cell surface markers (i.e., SSEA3, SSEA4, OCT4, TRA-1-60, and TRA-1-81), and gene expression for pluripotency (Oct-4 and nanog). They all formed embryoid bodies in suspension cultures, and after seeding in culture plates they showed pluripotency in vitro by forming cell lineages derived from all three germ layers as indicated by expression of the ectodermal marker nestin, the mesodermal marker renin, and the endodermal markers alpha-fetoprotein and GATA6. All clones showed normal expression of alkaline phosphatase activity, a marker of in vitro pluripotency. When hESC clones (1-2 x 10(6) total) were injected into nonobese diabetic-severe combined immunodeficiency (NOD-SCID) mice under the kidney capsule, all formed teratomas within 6-8 weeks. Analysis of the stem cell surface marker TRA-1-160 by flow cytometry showed nonsignificant (p < 0.05) differences between the clones and the parent line. The clones also differed in their expression of genes, with only one, hES 3.2, expressing the endodermal markers, i.e., alpha-fetoprotein and GATA6. The ability to produce clones from a parent hESC line rapidly by FACS sorting will help provide a homogeneous population of cells for achieving uniformed lineage specifications for future transplantation therapies and biomedical research.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16522163     DOI: 10.1089/scd.2006.15.61

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  13 in total

1.  Individual cell movement, asymmetric colony expansion, rho-associated kinase, and E-cadherin impact the clonogenicity of human embryonic stem cells.

Authors:  Li Li; Bill H Wang; Shuai Wang; Lilian Moalim-Nour; Kanishka Mohib; David Lohnes; Lisheng Wang
Journal:  Biophys J       Date:  2010-06-02       Impact factor: 4.033

2.  Dental follicle progenitor cell heterogeneity in the developing mouse periodontium.

Authors:  Xianghong Luan; Yoshihiro Ito; Smit Dangaria; Thomas G H Diekwisch
Journal:  Stem Cells Dev       Date:  2006-08       Impact factor: 3.272

Review 3.  Deconstructing human embryonic stem cell cultures: niche regulation of self-renewal and pluripotency.

Authors:  Morag H Stewart; Sean C Bendall; Mickie Bhatia
Journal:  J Mol Med (Berl)       Date:  2008-06-03       Impact factor: 4.599

4.  Derivation of a new human embryonic stem cell line, Endeavour-2, and its characterization.

Authors:  Kuldip S Sidhu; John P Ryan; Justin G Lees; Bernard E Tuch
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-02-23       Impact factor: 2.416

5.  A robust vitronectin-derived peptide for the scalable long-term expansion and neuronal differentiation of human pluripotent stem cell (hPSC)-derived neural progenitor cells (hNPCs).

Authors:  Divya Varun; Gayathri Rajaram Srinivasan; Yi-Huan Tsai; Hyun-Je Kim; Joshua Cutts; Francis Petty; Ryan Merkley; Nicholas Stephanopoulos; Dasa Dolezalova; Martin Marsala; David A Brafman
Journal:  Acta Biomater       Date:  2016-10-27       Impact factor: 8.947

6.  Label-free separation of human embryonic stem cells and their differentiating progenies by phasor fluorescence lifetime microscopy.

Authors:  Chiara Stringari; Robert Sierra; Peter J Donovan; Enrico Gratton
Journal:  J Biomed Opt       Date:  2012-04       Impact factor: 3.170

7.  Anti-human embryonic stem cell monoclonal antibody Hesca-2 binds to a glycan epitope commonly found on carcinomas.

Authors:  Mohamed G Shoreibah; Crystal L Jackson; Paul W Price; Richard Meagher; Andrew K Godwin; Qi Cai; Jeffrey C Gildersleeve
Journal:  Stem Cells Dev       Date:  2010-11-08       Impact factor: 3.272

8.  Derivation and cloning of a novel rhesus embryonic stem cell line stably expressing tau-green fluorescent protein.

Authors:  Florence Wianny; Agnieszka Bernat; Cyril Huissoud; Guillaume Marcy; Suzy Markossian; Véronique Cortay; Pascale Giroud; Vincent Leviel; Henry Kennedy; Pierre Savatier; Colette Dehay
Journal:  Stem Cells       Date:  2008-03-20       Impact factor: 6.277

9.  Fibromodulin reprogrammed cells: A novel cell source for bone regeneration.

Authors:  Chen-Shuang Li; Pu Yang; Kang Ting; Tara Aghaloo; Soonchul Lee; Yulong Zhang; Kambiz Khalilinejad; Maxwell C Murphy; Hsin Chuan Pan; Xinli Zhang; Benjamin Wu; Yan-Heng Zhou; Zhihe Zhao; Zhong Zheng; Chia Soo
Journal:  Biomaterials       Date:  2016-01-07       Impact factor: 12.479

10.  TRA-1-60+, SSEA-4+, Oct4A+, Nanog+ Clones of Pluripotent Stem Cells in the Embryonal Carcinomas of the Ovaries.

Authors:  Marek Malecki; Mark Anderson; Michael Beauchaine; Songwon Seo; Xenia Tombokan; Raf Malecki
Journal:  J Stem Cell Res Ther       Date:  2012-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.